This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Naoto Uemura: Innovator in Anti-Diabetic Treatments
Introduction
Naoto Uemura is a notable inventor based in Westfield, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of type II diabetes. His innovative approach focuses on the use of fused aromatic compounds that exhibit anti-diabetic activity.
Latest Patents
Uemura holds a patent for a "Method of treatment using fused aromatic compounds having anti-diabetic activity." This patent describes fused aromatic compounds of Formula I, which are identified as PPAR gamma agonists or partial agonists. These compounds are particularly useful for weekly dosing in the treatment or control of type II diabetes, addressing conditions such as hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes. He has 1 patent to his name.
Career Highlights
Naoto Uemura is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to focus on developing innovative treatments that can improve the quality of life for individuals suffering from diabetes.
Collaborations
Uemura has collaborated with notable colleagues, including Peter T Meinke and Andrew Evan Denker. These collaborations have contributed to the advancement of research and development in the field of diabetes treatment.
Conclusion
Naoto Uemura's contributions to the field of anti-diabetic treatments highlight his innovative spirit and dedication to improving healthcare. His work continues to pave the way for new therapeutic options for those affected by type II diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile